Martingale Asset Management L P Exelixis, Inc. Transaction History

Martingale Asset Management L P

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 10, 2021	SELL	$18.39 - $24.8 $355,239 - $479,061	-19,317 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$20.67 - $26.94 $59,880 - $78,045	2,897 Added 17.64%	19,317 $472,000
Q2 2020 Aug 10, 2020	BUY	$16.46 - $27.42 $270,273 - $450,236	16,420 New	16,420 $389,000
Q1 2020 May 11, 2020	SELL	$14.46 - $21.8 $434,074 - $654,414	-30,019 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$15.15 - $18.89 $342,435 - $426,970	-22,603 Reduced 42.95%	30,019 $528,000
Q3 2019 Nov 13, 2019	SELL	$17.68 - $22.65 $143,119 - $183,351	-8,095 Reduced 13.33%	52,622 $930,000
Q2 2019 Aug 13, 2019	BUY	$18.93 - $24.75 $308,331 - $403,128	16,288 Added 36.66%	60,717 $0
Q1 2019 May 08, 2019	BUY	$19.6 - $24.76 $870,808 - $1.1 Million	44,429 New	44,429 $0

564

251M

1.45M

1.13M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.3B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.